Flu vaccine coverage for recommended populations in France

IF 5 Q3 Medicine
J. Robert , B. Detournay , M.C. Levant , M. Uhart , J. Gourmelen , J.M. Cohen
{"title":"Flu vaccine coverage for recommended populations in France","authors":"J. Robert ,&nbsp;B. Detournay ,&nbsp;M.C. Levant ,&nbsp;M. Uhart ,&nbsp;J. Gourmelen ,&nbsp;J.M. Cohen","doi":"10.1016/j.medmal.2019.12.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>To estimate the size of the populations targeted by the French recommendations of the High Council for Public Health (French acronym HCSP) regarding vaccination against seasonal flu and to estimate vaccination coverage rates in these populations.</p></div><div><h3>Patients and methods</h3><p>The analysis was conducted on a representative sample of patients retrieved from the French Health Insurance databases during three influenza seasons (2012–2013, 2013–2014, 2014–2015). Patients targeted by the influenza vaccination recommendations were identified based on their sociodemographic characteristics and disease identification algorithms during each season. Vaccine coverage rates were estimated based on reimbursed influenza vaccines. Results were extrapolated using indirect standardization to the overall French population.</p></div><div><h3>Results</h3><p>Populations targeted by the recommendations were estimated after extrapolation to 17.6, 17.8, and 18.0 million for the 2012–13, 2013–14, and 2014–15 influenza seasons, respectively. The vaccination coverage rates in these target populations were respectively estimated at 32.1%, 31.9%, and 32.1%; i.e. 44.2%, 43.1%, and 42.7% for individuals aged ≥<!--> <!-->65 years and 12.9%, 13.2%, and 13.7% for individuals ˂<!--> <!-->65 years of age presenting a risk justifying vaccination.</p></div><div><h3>Conclusions</h3><p>Immunization coverage against influenza in France remains well below the target of 75% set by the World Health Organization. Multiple strategies combining communication, education, access program, and professional engagement could be implemented to improve this situation.</p></div>","PeriodicalId":18464,"journal":{"name":"Medecine et maladies infectieuses","volume":"50 8","pages":"Pages 670-675"},"PeriodicalIF":5.0000,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.medmal.2019.12.004","citationCount":"16","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medecine et maladies infectieuses","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0399077X19310807","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 16

Abstract

Objectives

To estimate the size of the populations targeted by the French recommendations of the High Council for Public Health (French acronym HCSP) regarding vaccination against seasonal flu and to estimate vaccination coverage rates in these populations.

Patients and methods

The analysis was conducted on a representative sample of patients retrieved from the French Health Insurance databases during three influenza seasons (2012–2013, 2013–2014, 2014–2015). Patients targeted by the influenza vaccination recommendations were identified based on their sociodemographic characteristics and disease identification algorithms during each season. Vaccine coverage rates were estimated based on reimbursed influenza vaccines. Results were extrapolated using indirect standardization to the overall French population.

Results

Populations targeted by the recommendations were estimated after extrapolation to 17.6, 17.8, and 18.0 million for the 2012–13, 2013–14, and 2014–15 influenza seasons, respectively. The vaccination coverage rates in these target populations were respectively estimated at 32.1%, 31.9%, and 32.1%; i.e. 44.2%, 43.1%, and 42.7% for individuals aged ≥ 65 years and 12.9%, 13.2%, and 13.7% for individuals ˂ 65 years of age presenting a risk justifying vaccination.

Conclusions

Immunization coverage against influenza in France remains well below the target of 75% set by the World Health Organization. Multiple strategies combining communication, education, access program, and professional engagement could be implemented to improve this situation.

法国推荐人群的流感疫苗覆盖率
目的估计法国公共卫生高级委员会(法语缩写HCSP)关于季节性流感疫苗接种的建议所针对的人群规模,并估计这些人群的疫苗接种覆盖率。患者和方法对三个流感季节(2012-2013年、2013-2014年、2014-2015年)从法国健康保险数据库中检索的具有代表性的患者样本进行了分析。根据每个季节的社会人口学特征和疾病识别算法确定流感疫苗接种建议的目标患者。疫苗覆盖率是根据已报销的流感疫苗估计的。使用间接标准化对整个法国人口进行外推。结果2012-13年、2013-14年和2014-15年流感季节,建议的目标人群分别为1760万人、1780万人和1800万人。这些目标人群的疫苗接种率分别估计为32.1%、31.9%和32.1%;也就是说,年龄≥65岁的个体有44.2%、43.1%和42.7%的风险,而年龄小于65岁的个体有12.9%、13.2%和13.7%的风险可以证明接种疫苗是合理的。结论:法国的流感疫苗接种率仍远低于世界卫生组织设定的75%的目标。可以实施多种策略,结合沟通、教育、访问计划和专业参与来改善这种情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medecine et maladies infectieuses
Medecine et maladies infectieuses 医学-传染病学
CiteScore
1.10
自引率
0.00%
发文量
0
审稿时长
10.7 weeks
期刊介绍: L''organe d''expression de la Société de Pathologie Infectieuse de Langue Française (SPILF). Médecine et Maladies Infectieuses is the official publication of the Société de Pathologie Infectieuse de Langue Française (SPILF). Médecine et Maladies Infectieuses is indexed in the major databases: Medline, Web of Science/Clarivate and Scopus. The journal publishes scientific /research articles, general reviews, short communications and letters, in both English and French. The journal welcomes submissions on the various aspects of infectious pathologies and pathogenic agents. Médecine et Maladies Infectieuses focuses on clinical therapeutics, nosocomial infections, biology, prevention, as well as epidemiology and therapeutics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信